title: Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab.
authors.affiliation: 1 AKH Viersen, Viersen, Germany ; 2 Kantonsspital St. Gallen, St. Gallen, Switzerland.
authors.forename: Johannes M
authors.initials: JM
authors.lastname: Wolff
authors.affiliation: 1 AKH Viersen, Viersen, Germany ; 2 Kantonsspital St. Gallen, St. Gallen, Switzerland.
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Schmid
references.citation: Lancet. 2012 Jan 7;379(9810):39-46
references.pmid: 22093187